Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkinʼs lymphoma - Dipersio, J F; Micallef, I N; Stiff, P J (J Clin Oncol, 2009)
et al.